Collagen Disorders - PowerPoint PPT Presentation

collagen disorders n.
Skip this Video
Loading SlideShow in 5 Seconds..
Collagen Disorders PowerPoint Presentation
Download Presentation
Collagen Disorders

play fullscreen
1 / 48
Download Presentation
Collagen Disorders
Download Presentation

Collagen Disorders

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Collagen Disorders Michael H. Wilhelm, CRNA, APRN

  2. Collagen Vascular Diseases The four most common disorders of this group are rheumatoid arthritis, systemic lupus erythematosus, scleroderma, and polymyositis. The etiology of the collagen vascular diseases is unknown, however the immune system has been implicated. All of these diseases effect the joints, each has systemic effects as well.

  3. Rheumatoid Arthritis • Pathophysiology • Rheumatoid arthritis begins with cellular hyperplasia of the synovium, followed by invasion of the synovium by lymphocytes, plasma cells, and fibroblasts. Ultimately, the cartilage and articular surfaces are destroyed. • The cause of Rheuatoid Arthritis is unknown, but rheumatoid factor (an antiimmunoglobulin antibody) is present in 90% of patients • The hands and wrist are the first to be effected, especially the metacarpophalangeal and proximal interphalangeal joints.

  4. Rheumatoid Arthritis • Compression of lower extremity peripheral nerves can produce paresis and sensory loss over the leg. • Spinal cord compression does not correlate with patient’s symptoms, and asymptomatic patients may have a high degree of cord compression. • Rheumatoid arthritis affects the joints of the larynx, cervical spine, and temporomandibular joint.

  5. Rheumatoid Arthritis • Peripheral Joints • Hands, feet, wrist (most common) • Nonarticular muscular structures • Tendons, ligaments and fascia • Systemic Involvement • Blood Vessels, heart, lungs, etc.

  6. Rheumatoid Arthritis • Manifestations involving other systems: • Skin : Raynaud’s, Digital necrosis • Eyes : Scleritis, corneal ulceration • Lung : Pleural effusion, pulmonary effusion • Heart : Pericarditis, cardiac tamponade, coronary arteritis, aortic insufficiency • Kidney : Interstitial fibrosis, glomerulonephritis, amyloid deposition • PNS : Compression syndromes, mononeuritis

  7. Rheumatoid Arthritis • Manifestations continued: • Liver : Hepatitis • Blood: Anemia, leukopenia

  8. Rheumatoid Arthritis • About 6 million American have Rheumatoid Arthritis • 75% of them are women • Can occur at any age • Women: between ages 35-50 • Men: somewhat later

  9. Rheumatoid Arthritis • Joint Involvement • Morning Stiffness – joints of the hand, feet, wrist and knees • Nearly every joint is effected • Thoracic, lumbar, sacral spine almost always spared • Cervical spine involvement is frequent • Atlantoaxialsubluxation (partial or complete dislocation of the 1st and 2nd cervical vertebrae) • Cricoarytenoidarthritus • Edema of the arytenoids, upper airway obstruction • Tempromandibular Joint • Limitations in mandibular motion • Joints of the Larynx • Limitations of the vocal cord movement, edema

  10. Rheumatoid Arthritis • Systemic Involvement • Vascular • Vasculitis – peripheries • Aortitus – dilation of the aortic root resulting in aortic regurgitation • Cardiovascular • Pericarditus, endocarditis, LV Failure (CHF), valve fibrosis, arteritis involving coronary arteries, myocardial infarction • Pulmonary • Pleural effusions, fibrosis • Costochondral involvement • Decreases lung volumes • Decreases vital capacity • Leads to V/Q Mismatch decreasing arterial oxygenation

  11. Rheumatoid Arthritis • Neuromuscular • Loss of strength in muscle adjacent to joints • Neuropathy resulting from nerve compression • Hematologic • Anemia • Liver/Kidney • Rarely problems occur

  12. Rheumatoid Arthritis

  13. Rheumatoid Arthritis

  14. Rheumatoid Arthritis • Treatment: • Analgesics, NSAIDS,Methotrexate, COX-2 inhibitors, and corticosteroids. • Many of these dugs cause anemia, thrombocytopenia, and hepatitis. • Steroids are reserved for those patients who fail to respond to first line drugs such as Methotrexate due to the long term effects of taking steroids. • Surgical procedures such as synovectomy, tenolysis, and joint replacement.

  15. Rheumatoid Arthritis • Management of anesthesia: • Baseline ABGs, PFTs, clotting times, CBC, ECHO/Stress Test • Assess cervical spine ROM and airway • Assess steroid use • Possible awake FOI, glidescope • Proper positioning • Careful airway management/ventilation

  16. Rheumatoid Arthritis • Management of anesthesia: • Intubation: cricoarytenois arthritis may be recognized by erythema and edema of vocal cords which may decrease glottic opening. A smaller ETT may be needed. Exaggerated edema and stridor may occur postextubation. • Corticosteroids may be needed perioperatively. • Careful positioning.

  17. Systemic Lupus Erythematosus An autoimmune disease in which patients produce autoantibodies to DNA and also to RNA polymerase, cardiolipin, and ribosomal phosphoproteins. Clinical manifestations may be due to the production of and autoantibody highly specific for a single protein within an organ. Common manifestations are polyarthritis and dermatitis.

  18. Systemic Lupus Erythematosus • A diagnosis of SLE is likely when patients have three of four manifestations • Antinuclear antibodies • Characteristic rash • Thrombocytopenia • Serositis • Nephritis • Common Presenting Features • Fever • Malaise • Joint Pain • Myalgias • Fatigue

  19. Systemic Lupus Erythematosus About 1.5 Million Americans have SLE Affects women 9 times more likely than men Can occur at any age Higher incident in African-American women

  20. Systemic Lupus Erythematosus • Systemic Involvement • Cardiovascular • Pericarditis, pericardial effusions, friction rub, tachycardia, CHF, LV dysfunction, valve abnormalities (aortic, mitral) • Pulmonary • Pleural effusions, pneumonia, dry cough, dyspnea, pulmonary HTN • PFTs show restrictive lung disease • Recurrent atelectasis can result in “shrinking lung syndrome” • Involvement of the larynx and the trachea is rare, but may include true vocal fold thickening or paralysis, cricoarytenois arthritis, and subglotticstenosis

  21. Systemic Lupus Erythematosus • CNS • Cognitive dysfunction occurs in approximately 1/3 of the patients • Mood Disturbances • Deterioration of intellectual capacity • Atypical migraine headaches followed by visual disturbances • Cutaneous • Mala or “butterfly” rash is presenting sign in 50% of patients • Rash on trunk (red scaly patches), alopecia • Photosensitivity

  22. Systemic Lupus Erythematosus • Neuromuscular • Loss of strength in muscle adjacent to joints • Neuropathy resulting from nerve compression • Hematologic • Anemia, Thrombocytopenia, leukopenia, Prolonged PT and PTT • Liver • Autoimmune Hepatitis in severe cases • Kidney • Glomerulonephritis, proteinuria, hypoalbuminemia, renal failure

  23. Systemic Lupus Erythematosus

  24. Systemic Lupus Erythematosus

  25. Systemic Lupus Erythematosus IMMUNOLOGY • OMG

  26. Systemic Lupus Erythematosus • Management of Anesthesia: • Careful pre-operative assessment including CXR, echo, renal function, liver function, and PFT’s. • Airway Assessment • Proper Positions/Peripheral Neuropathy • Careful muscle relaxation titration • Arthritic involvement is rare in the cervical spine. • If postextubation laryngeal edema or stridor occur IV administration of corticosteroids is effective. • Patients receiving corticosteroids may require intraoperative steroids.

  27. Scleroderma A chronic autoimmune disease of the connective tissue Characterized by the formation of scar tissue (fibrosis) in the skin and organs of the body and presence of autoantibodies The cause of Scleroderma is unknown, but the disease process has the characteristics of both a collagen disease and an autoimmune process Progressive fibrosis, resulting form increases collagen deposits in the interstitium and intima of small arteries and connective tissue of involved organs is the pathologic hall mark of the disease

  28. Scleroderma Affects approximately 300,000 people in the US Affects women 4 times more likely than men Juvenile scleroderma affects approximately 7000 children in the US Choctaw Native Americans have the highest reported prevalence Men and African-American women have the worse prognosis

  29. Scleroderma • Limited form of Scleroderma tends to be confined to the skin, fingers and face • Often referred to as “CREST” Syndrome • C – Calcinosis – Calcium deposits in the skin • R – Raynaud’s Phenomenon – Spasms of tiny blood vessels in response to cold or stress • E – Esophagus Dysfunction – Acid reflux and decreased motility of the esophagus • S – Sclerodactyly – Thickening and tightening of the skin on the fingers and hands • T – Telangiectasis – Dilation of capillaries causing red marks on surface of the skin

  30. Scleroderma • Systemic Involvement • Skin/Musculoskeletal • Inflammation and taut skin leading to decreased ROM of the fingers, toes and jaw • Skeletal muscle myopathy leading to muscle weakness • Cardiovascular • Sclerosis of coronary arteries, fibrous tissue replaces cardiac muscle, systemic and pulmonary HTN • Dysrhythmias, cardiac conduction abnormalities, CHF, pericarditis, pericardial effusion

  31. Scleroderma • Pulmonary • Interstitial fibrosis, pulmonary HTN, decreases inspiratory capacity, increases residual volume, chest wall restriction • GI • GI fibrosis, hypomotility of the esophagus and small intestine, decreased lower esophageal sphincter tone, reflux esophagitis • Renal • Renal artery obstruction, decreased renal blood flow, systemic HTN, renal failure

  32. Scleroderma

  33. Scleroderma • Management of anesthesia: • Baseline ABGs, PFTs, CXR, EKG, Room Air Sat • Full stomach precautions • Managing BP/Fluid Mangement • Avoid hypothermia • Careful airway management/ventilation • Avoid hypoxemia and respiratory acidosis • Possible awake FOI, glidescope

  34. Scleroderma • Regional Anesthesia • Advantages • Post operative analgesia • Peripheral vasodilation • Decreased risk of post operative ventilation support • Disadvantages • Regional Anesthesia may be technically difficult due to the taut skin and joint changes

  35. Scleroderma • Management of Anesthesia: • Ventilation with increased FiO2 is required • Invasive cardiac monitoring due to exaggerated responses to inhaled anesthetics. • Difficult venous access. • Muscle involvement may increase sensitivity to muscle relaxants (use short acting). • Regional anesthetics may be prolonged. • Avoid stellate ganglion block.

  36. Marfan’s Syndrome Autosomal dominant, multisystem, fibrous connective tissue disorder Affects blood vessel walls, tendons, ligaments, cartilage, heart walls/valves, aorta, and other structures Characterized by disproportionately long limbs, long thin fingers, a typically tall stature and a predisposition to cardiovascular abnormalities

  37. Marfan’s Syndrome Approximately 200,000 people in the US Each parent with the condition has a 50% chance of passing onto offspring Men and women are equally likely to have disease Caused by a mutation of a gene on Chromosome 15

  38. Marfan’s Syndrome • Systemic Involvement • Musculoskeletal • Grows to about average height • Arachnodactyly (long slender limbs, fingers and toes) • Scoliosis, thoracic lordosis • Pectusexcavatum or pectuscairnatum • High palates and jaws • Cardiovascular • Dilated aorta, risk of ruptured aortic aneurysm • Prolapse of the mitral or aortic valves • Palpitations, tachydysrhythmia • Raynaud’s Phenomenon

  39. Marfan’s Syndrome • Pulmonary • Spontaneous Pneumothorax • Sleep Apnea • Obstructive Lung Disease • CNS • Dural ectasia (weaking of the connective tissue of the dural sac) • Lower back pain, leg pain, abdominal pain, neuropathy, headache • Eye • Retinal detachment, glaucoma, lens discoloration, myopia, corneal flatness

  40. Marfan’s Syndrome

  41. Marfan’s Syndrome • Anesthesia Management • Careful airway management • Minimize pain/stress • Positioning • Cardiac Workup • Careful Ventilation • Careful blood pressure monitoring • Intraoperative Medications • Beta Blockers • ACE Inhibitors • ARBs • Antibiotics

  42. EpidermolysisBullosa A rare skin disease which can be inherited or acquired. The acquired forms are autoimmune. The end result is loss or absence of normal intercellular bridges and separation of skin layers. The separation of skin layers results in intradermal fluid accumulation and bullae formation. Minor skin trauma produces skin blisters.

  43. Epidermolysis Bullosa Involves fingers and toes mostly. Esophageal involvement is common, resulting in dysphasia and esophageal strictures Anemia and hypoalbuminemia lead to increased infection. Glomerulonephritis secondary to strep infection. Patients rarely survive over 30 years.

  44. Epidermolysis Bullosa • Therapy is rather unsuccessful and steroids tend not to work. • Management of Anesthesia: • Avoid trauma to the skin and mucous membranes • Trauma from tape, BP cuffs, tourniquets, and EKG pads can cause bullae. • Pad BP cuffs • Lubrication of face mask • Avoid upper airways.

  45. Epidermolysis Bullosa Management of anesthesia: Lubricate laryngoscope to reduce friction. Scarring of the oral cavity can produce immobility of the tongue, therefore consider awake fiberoptic. Avoid esophageal stethoscopes. Ketamine is a good choice due to most surgeries are superficial and to the extremities. Regional has been successful.

  46. Pemphigus An autoimmune disease where auto antibodies are highly specific and result in the excessive production of proteolytic enzymes that disrupt cell adhesion, leading to separation of epithelial layers. Pemphigus vulgaris is most common and most clinically important to anesthesiologists because of the occurrence of oral lesions. Lesions of the pharynx, larynx, esophagus, conjunctiva, urethra, cervix, and anus also develop.

  47. Pemphigus • Treatment with corticosteroids and immunosupressants is highly effective. • Management of Anesthesia: • Corticosteroid supplementation. • Upper airway techniques are similar to epidermolysisbullosa. • Ketamine and regional are also successful for these patients. • Look for side effects of treatment drugs with anesthesia. Such as cyclophosphamide may prolong SCH and mivacurium by inhibiting cholinesterase activity.

  48. Questions ?